|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
FY2017
12 months to Dec 31, 2017
|
|
|---|---|---|---|---|---|
| Revenues: | |||||
| Net product sales | |||||
| Total net product sales | |||||
| Collaboration revenue | |||||
| Total revenues | |||||
| Operating costs and expenses: | |||||
| Cost of product sales (excluding intangible asset amortization) | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Intangible asset amortization | |||||
| Acquired in-process research and development and related costs | |||||
| Loss on contract termination | |||||
| Change in fair value of contingent consideration | |||||
| Asset impairment charges | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense): | |||||
| Interest income | |||||
| Interest expense | |||||
| Loss on extinguishment of debt | |||||
| Change in fair value of common stock warrant liabilities | |||||
| Other income, net | |||||
| Total other income (expense) | |||||
| Loss from operations before income taxes | |||||
| Income tax expense (benefit) | |||||
| Loss from continuing operations | |||||
| Loss from discontinued operations | |||||
| Net loss | |||||
| Continuing operations (in usd per share) | |||||
| Discontinued operations (in usd per share) | |||||
| Net loss per share, basic (in dollars per share) | |||||
| Net loss per share, diluted (in dollars per share) | |||||
| Weighted average common shares outstanding, basic (in shares) | |||||
| Weighted average common shares outstanding, diluted (in shares) | |||||
Loading...